Clinical Trial Update: Prophylactic Use of Filgrastim SD/01 in Patients With Hodgkin's Disease Receiving ABVD Chemotherapy [Phase 3]

View source ↗

Summary

A Phase 3 trial evaluating prophylactic use of Filgrastim SD/01 in Hodgkin disease patients undergoing ABVD chemotherapy has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hodgkin Lymphoma

Drugs mentioned

• Filgrastim-SD/01 (filgrastim)

Snippet

Sponsor: M.D. Anderson Cancer Center | Conditions: Hodgkin Disease | Phase 3 | Status: COMPLETED